|
1
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:2916–27. 2016. View Article : Google Scholar
|
|
2
|
Chen M, Liu X, Du J, Wang XJ and Xia L:
Differentiated regulation of immune-response related genes between
LUAD and LUSC subtypes of lung cancers. Oncotarget. 8:133–144.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoshioka H, Shimokawa M, Seto T, Morita S,
Yatabe Y, Okamoto I, Tsurutani J, Satouchi M, Hirashima T, Atagi S,
et al: Final overall survival results of WJTOG3405, a randomized
phase III trial comparing gefitinib versus cisplatin with docetaxel
as the first-line treatment for patients with stage IIIB/IV or
postoperative recurrent EGFR mutation-positive non-small-cell lung
cancer. Ann Oncol. 30:1978–1984. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bobbili P, Ryan K, Duh MS, Dua A,
Fernandes AW, Pavilack M and Gomez JE: Treatment patterns and
overall survival among patients with unresectable, stage III
non-small-cell lung cancer. Future Oncol. 15:3381–3393. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
León-Atance P, Moreno-Mata N,
González-Aragoneses F, Cañizares-Carretero MA, García-Jiménez MD,
Genovés-Crespo M, Honguero-Martínez AF, Rombolá CA, Simón-Adiego CM
and Peñalver-Pascual R: Multicenter analysis of survival and
prognostic factors in pathologic stage I non-small-cell lung cancer
according to the new 2009 TNM Classification. Arch Bronconeumol.
47:441–446. 2011.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Criss SD, Mooradian MJ, Watson TR, Gainor
JF, Reynolds KL and Kong CY: Cost-effectiveness of atezolizumab
combination therapy for first-line treatment of metastatic
nonsquamous non-small cell lung cancer in the United States. JAMA
Netw Open. 2:e19119522019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rosser CJ and Goodison S: CD24, a
promising biomarker in NSCLC. Biomark Med. 4:4952010. View Article : Google Scholar
|
|
8
|
Zhan SJ, Liu B and Linghu H: Identifying
genes as potential prognostic indicators in patients with serous
ovarian cancer resistant to carboplatin using integrated
bioinformatics analysis. Oncol Rep. 39:2653–2663. 2018.PubMed/NCBI
|
|
9
|
Sun C, Huang S, Wang H, Xie R, Zhang L,
Zhou Q, He X and Ju W: Non-SMC condensin I complex subunit H
enhances proliferation, migration, and invasion of hepatocellular
carcinoma. Mol Carcinog. 58:2266–2275. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hirano T: Condensins: Universal organizers
of chromosomes with diverse functions. Genes Dev. 26:1659–1678.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wood AJ, Severson AF and Meyer BJ:
Condensin and cohesin complexity: The expanding repertoire of
functions. Nat Rev Genet. 11:391–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kimura K, Cuvier O and Hirano T:
Chromosome condensation by a human condensin complex in xenopus egg
extracts. J Biol Chem. 276:5417–5420. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martin CA, Murray JE, Carroll P, Leitch A,
Mackenzie KJ, Halachev M, Fetit AE, Keith C, Bicknell LS, Fluteau
A, et al: Mutations in genes encoding condensin complex proteins
cause microcephaly through decatenation failure at mitosis. Genes
Dev. 30:2158–2172. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin L, Jiang LP, Shen QS, Xiong QX, Zhuo
X, Zhang LL, Yu HJ, Guo X, Luo Y, Dong J, et al: NCAPH plays
important roles in human colon cancer. Cell Death Dis. 8:e26802017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ryu B, Kim DS, Deluca AM and Alani RM:
Comprehensive expression profiling of tumor cell lines identifies
molecular signatures of melanoma progression. PLoS One. 2:e5942007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu L, Jiang Y, Zheng J, Xie G, Li J, Shi L
and Fan S: Aberrant expression of β-catenin and e-cadherin is
correlated with poor prognosis of nasopharyngeal cancer. Hum
Pathol. 44:1357–1364. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Granville CA and Dennis PA: An overview of
lung cancer genomics and proteomics. Am J Respir Cell Mol Biol.
32:169–176. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kozopas KM, Yang T, Buchan HL, Zhou P and
Craig RW: MCL1, a gene expressed in programmed myeloid cell
differentiation, has sequence similarity to BCL2. Proc Natl Acad
Sci USA. 90:3516–3520. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han Y, Wu N, Jiang M, Chu Y, Wang Z, Liu
H, Cao J, Liu H, Xu B and Xie X: Long non-coding RNA MYOSLID
functions as a competing endogenous RNA to regulate MCL-1
expression by sponging miR-29c-3p in gastric cancer. Cell Prolif.
52:e126782019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kour S, Rana S, Contreras JI, King HM,
Robb CM, Sonawane YA, Bendjennat M, Crawford AJ, Barger CJ, Kizhake
S, et al: CDK5 inhibitor downregulates Mcl-1 and sensitizes
pancreatic cancer cell lines to navitoclax. Mol Pharmacol.
96:419–429. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meister MT, Boedicker C, Linder B, Kogel
D, Klingebiel T and Fulda S: Concomitant targeting of Hedgehog
signaling and MCL-1 synergistically induces cell death in
Hedgehog-driven cancer cells. Cancer Lett. 465:1–11. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akgul C: Mcl-1 is a potential therapeutic
target in multiple types of cancer. Cell Mol Life Sci.
66:1326–1336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang H, Guttikonda S, Roberts L, Uziel T,
Semizarov D, Elmore SW, Leverson JD and Lam LT: Mcl-1 is critical
for survival in a subgroup of non-small-cell lung cancer cell
lines. Oncogene. 30:1963–1968. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Whitsett TG, Mathews IT, Cardone MH, Lena
RJ, Pierceall WE, Bittner M, Sima C, LoBello J, Weiss GJ and Tran
NL: Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer
survival and therapeutic response. Mol Cancer Res. 12:550–559.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang S, Kim CY, Hwang S, Kim E, Kim H,
Shim H and Lee I: COEXPEDIA: Exploring biomedical hypotheses via
co-expressions associated with medical subject headings (MeSH).
Nucleic Acids Res. 45(D1):D389–D396. 2017. View Article : Google Scholar
|
|
26
|
Travis WD, Brambilla E, Burke AP, Marx A
and Nicholson AG: WHO Classification of tumours of the lung,
pleura, thymus and heart. WHO Classification of Tumours. 7. 4th.
IARC; Lyon: 2015
|
|
27
|
Boffa DJ and Greene FL: Reacting to
changes in staging designations in the 7th edition of the AJCC
staging manual. Ann Surg Oncol. 18:1–3. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wen Q, Wang W, Luo J, Chu S, Chen L, Xu L,
Zang H, Alnemah MM, Ma J and Fan S: CGP57380 enhances efficacy of
RAD001 in non-small cell lung cancer through abrogating mTOR
inhibition-induced phosphorylation of eIF4E and activating
mitochondrial apoptotic pathway. Oncotarget. 7:27787–27801. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wen Q, Wang W, Chu S, Luo J, Chen L, Xie
G, Xu L, Li M and Fan S: Flot-2 expression correlates with EGFR
levels and poor prognosis in surgically resected non-small cell
lung cancer. PLoS One. 10:e01321902015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taylor AM, Shih J, Ha G, Gao GF, Zhang X,
Berger AC, Schumacher SE, Wang C, Hu H, Liu J, et al: Genomic and
functional approaches to understanding cancer aneuploidy. Cancer
Cell. 33:676–689.e673. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jordan EJ, Kim HR, Arcila ME, Barron D,
Chakravarty D, Gao J, Chang MT, Ni A, Kundra R, Jonsson P, et al:
Prospective comprehensive molecular characterization of lung
adenocarcinomas for efficient patient matching to approved and
emerging therapies. Cancer Discov. 7:596–609. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Janjigian YY, Sanchez-Vega F, Jonsson P,
Chatila WK, Hechtman JF, Ku GY, Riches JC, Tuvy Y, Kundra R,
Bouvier N, et al: Genetic predictors of response to systemic
therapy in esophagogastric cancer. Cancer Discov. 8:49–58. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Soumerai TE, Donoghue MTA, Bandlamudi C,
Srinivasan P, Chang MT, Zamarin D, Cadoo KA, Grisham RN,
O'Cearbhaill RE, Tew WP, et al: Clinical utility of prospective
molecular characterization in advanced endometrial cancer. Clin
Cancer Res. 24:5939–5947. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Witkiewicz AK, McMillan EA, Balaji U, Baek
G, Lin WC, Mansour J, Mollaee M, Wagner KU, Koduru P, Yopp A, et
al: Whole-exome sequencing of pancreatic cancer defines genetic
diversity and therapeutic targets. Nat Commun. 6:67442015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghandi M, Huang FW, Jané-Valbuena J,
Kryukov GV, Lo CC, McDonald ER III, Barretina J, Gelfand ET,
Bielski CM, Li H, et al: Next-generation characterization of the
cancer cell line encyclopedia. Nature. 569:503–508. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yaeger R, Chatila WK, Lipsyc MD, Hechtman
JF, Cercek A, Sanchez-Vega F, Jayakumaran G, Middha S, Zehir A,
Donoghue MTA, et al: Clinical sequencing defines the genomic
landscape of metastatic colorectal cancer. Cancer Cell.
33:125–136.e3. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pereira B, Chin SF, Rueda OM, Vollan HK,
Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ,
et al: The somatic mutation profiles of 2,433 breast cancers
refines their genomic and transcriptomic landscapes. Nat Commun.
7:114792016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42((Database Issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Neuwald AF and Hirano T: HEAT repeats
associated with condensins, cohesins, and other complexes involved
in chromosome-related functions. Genome Res. 10:1445–1452. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lawrimore J and Bloom K: The regulation of
chromosome segregation via centromere loops. Crit Rev Biochem Mol
Biol. 54:352–370. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Senichkin VV, Streletskaia AY, Zhivotovsky
B and Kopeina GS: Molecular comprehension of Mcl-1: From gene
structure to cancer therapy. Trends Cell Biol. 29:549–562. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Song L, Coppola D, Livingston S, Cress D
and Haura EB: Mcl-1 regulates survival and sensitivity to diverse
apoptotic stimuli in human non-small cell lung cancer cells. Cancer
Biol Ther. 4:267–276. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang H, Shah K, Bradbury NA, Li C and
White C: Mcl-1 promotes lung cancer cell migration by directly
interacting with VDAC to increase mitochondrial Ca2+ uptake and
reactive oxygen species generation. Cell Death Dis. 5:e14822014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mojsa B, Lassot I and Desagher S: Mcl-1
ubiquitination: Unique regulation of an essential survival protein.
Cells. 3:418–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Young AI, Timpson P, Gallego-Ortega D,
Ormandy CJ and Oakes SR: Myeloid cell leukemia 1 (MCL-1), an
unexpected modulator of protein kinase signaling during invasion.
Cell Adh Migr. 12:513–523. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fujise K, Zhang D, Liu J and Yeh ET:
Regulation of apoptosis and cell cycle progression by MCL1:
Differential role of proliferating cell nuclear antigen. J Biol
Chem. 275:39458–39465. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jamil S, Mojtabavi S, Hojabrpour P, Cheah
S and Duronio V: An essential role for MCL-1 in ATR-mediated CHK1
phosphorylation. Mol Biol Cell. 19:3212–3220. 2008. View Article : Google Scholar : PubMed/NCBI
|
